Research output per year
Research output per year
Personal profile
Research interests
My research program focuses on:
1. Gene down regulation strategies (RNAi and antisense oligonucleotides) to understand disease pathogenesis and provide novel therapies for neurodegenerative diseases, in particular amyotrophic lateral sclerosis (ALS)
2. How dysfunction of mitochondria causes loss of motor neurons.
Clinical interests
ALS and neurological disorders
Available to Mentor:
- PhD/MSTP Students
Fingerprint
Dive into the research topics where Timothy Miller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
HEALEY ALS Platform Trial Study Group, Feb 3 2025, In: JAMA Network Open. 8, 2, p. e2459058Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis
Trautwig, A. N., Fox, E. J., Dammer, E. B., Shantaraman, A., Ping, L., Duong, D. M., Watson, C. M., Wu, F., Asress, S., Guo, Q., Levey, A. I., Lah, J. J., Verde, F., Doretti, A., Ratti, A., Ticozzi, N., Ly, C. V., Miller, T. M., Garret, M. A. & Berry, J. D. & 5 others, , Dec 2025, In: Molecular neurodegeneration. 20, 1, 58.Research output: Contribution to journal › Article › peer-review
-
Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a “real-world” setting
Smith, S. E., McCoy-Gross, K., Malcolm, A., Oranski, J., Markway, J. W., Miller, T. M. & Bucelli, R. C., Feb 2025, In: Annals of Clinical and Translational Neurology. 12, 2, p. 311-319 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis
The ALL ALS Consortium, Dec 2024, In: Muscle and Nerve. 70, 6, p. 1140-1150 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD
Irwin, K. E., Jasin, P., Braunstein, K. E., Sinha, I. R., Garret, M. A., Bowden, K. D., Chang, K., Troncoso, J. C., Moghekar, A., Oh, E. S., Raitcheva, D., Bartlett, D., Miller, T., Berry, J. D., Traynor, B. J., Ling, J. P. & Wong, P. C., Feb 2024, In: Nature medicine. 30, 2, p. 382-393 12 p.Research output: Contribution to journal › Article › peer-review
Open Access49 Scopus citations